NCT01851512View on ClinicalTrials.gov

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

April 30, 2011

Conditions
InfertilityInduction of Ovulation
Interventions
DRUG

T-R (Test-Reference drug)

DRUG

R-T (Reference-Test drug)

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY